527 related articles for article (PubMed ID: 21419202)
1. Physical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: effect of pore and particle size.
Shen SC; Ng WK; Chia L; Hu J; Tan RB
Int J Pharm; 2011 May; 410(1-2):188-95. PubMed ID: 21419202
[TBL] [Abstract][Full Text] [Related]
2. Stabilized amorphous state of ibuprofen by co-spray drying with mesoporous SBA-15 to enhance dissolution properties.
Shen SC; Ng WK; Chia L; Dong YC; Tan RB
J Pharm Sci; 2010 Apr; 99(4):1997-2007. PubMed ID: 19816955
[TBL] [Abstract][Full Text] [Related]
3. Effects of particle morphology, pore size and surface coating of mesoporous silica on Naproxen dissolution rate enhancement.
Guo Z; Liu XM; Ma L; Li J; Zhang H; Gao YP; Yuan Y
Colloids Surf B Biointerfaces; 2013 Jan; 101():228-35. PubMed ID: 23010024
[TBL] [Abstract][Full Text] [Related]
4. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
5. Physical state of poorly water soluble therapeutic molecules loaded into SBA-15 ordered mesoporous silica carriers: a case study with itraconazole and ibuprofen.
Mellaerts R; Jammaer JA; Van Speybroeck M; Chen H; Van Humbeeck J; Augustijns P; Van den Mooter G; Martens JA
Langmuir; 2008 Aug; 24(16):8651-9. PubMed ID: 18630936
[TBL] [Abstract][Full Text] [Related]
6. Solid State NMR Characterization of Ibuprofen:Nicotinamide Cocrystals and New Idea for Controlling Release of Drugs Embedded into Mesoporous Silica Particles.
Skorupska E; Kaźmierski S; Potrzebowski MJ
Mol Pharm; 2017 May; 14(5):1800-1810. PubMed ID: 28403609
[TBL] [Abstract][Full Text] [Related]
7. High drug load, stable, manufacturable and bioavailable fenofibrate formulations in mesoporous silica: a comparison of spray drying versus solvent impregnation methods.
Hong S; Shen S; Tan DC; Ng WK; Liu X; Chia LS; Irwan AW; Tan R; Nowak SA; Marsh K; Gokhale R
Drug Deliv; 2016; 23(1):316-27. PubMed ID: 24853963
[TBL] [Abstract][Full Text] [Related]
8. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
[TBL] [Abstract][Full Text] [Related]
9. Mesoporous silica material TUD-1 as a drug delivery system.
Heikkilä T; Salonen J; Tuura J; Hamdy MS; Mul G; Kumar N; Salmi T; Murzin DY; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP
Int J Pharm; 2007 Feb; 331(1):133-8. PubMed ID: 17046183
[TBL] [Abstract][Full Text] [Related]
10. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole.
Kinnari P; Mäkilä E; Heikkilä T; Salonen J; Hirvonen J; Santos HA
Int J Pharm; 2011 Jul; 414(1-2):148-56. PubMed ID: 21601623
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility.
Potta SG; Minemi S; Nukala RK; Peinado C; Lamprou DA; Urquhart A; Douroumis D
J Microencapsul; 2011; 28(1):74-81. PubMed ID: 21171818
[TBL] [Abstract][Full Text] [Related]
12. Potential of amorphous microporous silica for ibuprofen controlled release.
Aerts CA; Verraedt E; Depla A; Follens L; Froyen L; Van Humbeeck J; Augustijns P; Van den Mooter G; Mellaerts R; Martens JA
Int J Pharm; 2010 Sep; 397(1-2):84-91. PubMed ID: 20619331
[TBL] [Abstract][Full Text] [Related]
13. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
[TBL] [Abstract][Full Text] [Related]
14. Low-Field NMR to Characterize the Crystalline State of Ibuprofen Confined in Ordered or Nonordered Mesoporous Silica.
Okada K; Hayashi Y; Tsuji T; Onuki Y
Chem Pharm Bull (Tokyo); 2022; 70(8):550-557. PubMed ID: 35908921
[TBL] [Abstract][Full Text] [Related]
15. Mesoporous silica nanoparticles with manipulated microstructures for drug delivery.
Chen Z; Li X; He H; Ren Z; Liu Y; Wang J; Li Z; Shen G; Han G
Colloids Surf B Biointerfaces; 2012 Jun; 95():274-8. PubMed ID: 22494670
[TBL] [Abstract][Full Text] [Related]
16. Determination of the physical state of drug molecules in mesoporous silicon with different surface chemistries.
Riikonen J; Mäkilä E; Salonen J; Lehto VP
Langmuir; 2009 Jun; 25(11):6137-42. PubMed ID: 19466777
[TBL] [Abstract][Full Text] [Related]
17. Facile synthesis of 3D cubic mesoporous silica microspheres with a controllable pore size and their application for improved delivery of a water-insoluble drug.
Hu Y; Wang J; Zhi Z; Jiang T; Wang S
J Colloid Interface Sci; 2011 Nov; 363(1):410-7. PubMed ID: 21820127
[TBL] [Abstract][Full Text] [Related]
18. Surface chemistry and pore size affect carrier properties of mesoporous silicon microparticles.
Limnell T; Riikonen J; Salonen J; Kaukonen AM; Laitinen L; Hirvonen J; Lehto VP
Int J Pharm; 2007 Oct; 343(1-2):141-7. PubMed ID: 17600644
[TBL] [Abstract][Full Text] [Related]
19. Practical approach to prepare solid dispersion drug product using spherical silicate.
Nagane K; Kimura S; Ukai K; Ogawa N; Yamamoto H
Int J Pharm; 2014 Nov; 475(1-2):364-71. PubMed ID: 25131150
[TBL] [Abstract][Full Text] [Related]
20. Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system.
Yang P; Huang S; Kong D; Lin J; Fu H
Inorg Chem; 2007 Apr; 46(8):3203-11. PubMed ID: 17371013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
